Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the Aesthetic Surgery Journal (ASJ), a leading academic journal in aesthetic medicine and plastic surgery. Following the publication of...
Hence then, the article about caliway s fat reduction drug cbl 514 phase 2 clinical results accepted by asj cbl 0204 s demonstrated efficacy and safety gain further academic recognition was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Caliway's Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204's Demonstrated Efficacy and Safety Gain Further Academic Recognition )
Also on site :
- Trump Calls Pope Leo & 039;Weak on Crime,& 039; Tells Him to & 039;Get His Act Together& 039;
- Sinner beats Alcaraz in straight sets to win Monte Carlo; reclaim No.1 spot
- Crumbl Unveils a New Take on a Classic Flavor